Dear all, 

please see below for your information.

Kind regards, Chris

--
Dr. Christoph Steinbeck, Head of Cheminformatics and Metabolism
European Bioinformatics Institute (EMBL-EBI), European Molecular Biology 
Laboratory
Wellcome Trust Genome Campus, Hinxton, Cambridge CB10 1SD, UK
Phone +44 1223 49 2640, Email: steinb...@ebi.ac.uk, Admin: khol...@ebi.ac.uk
https://www.ebi.ac.uk/about/people/christoph-steinbeck
http://orcid.org/0000-0001-6966-0814
> 
> 
> Dear Dr. Christoph Steinbeck,
> 
> ACS is pleased to share that your final published article:
> 
> The Blue ObelisksInteroperability in Chemical Informatics  ci050400b
> 
> has been successfully deposited for immediate availability after the date of 
> first web publication to PubMed Central (PMC) as part of ACS' Certified 
> Deposit program, one of the benefits of choosing an ACS AuthorChoice option.
> 
> The article has been assigned 
> 
> PMCID# PMC4878861  
> 
> This ID number can now be used for grant reporting purposes. You are also 
> encouraged to forward this PMCID to your institution's open access manager.
> 
> Please contact supp...@services.acs.org should you have any questions.
> 
> Best Regards,
> 
> Lisa Dove,
> Sr. Manuscript Processor
> ACS Journal Publications
> ld...@acs.org
> mprece...@acs.org


------------------------------------------------------------------------------
Mobile security can be enabling, not merely restricting. Employees who
bring their own devices (BYOD) to work are irked by the imposition of MDM
restrictions. Mobile Device Manager Plus allows you to control only the
apps on BYO-devices by containerizing them, leaving personal data untouched!
https://ad.doubleclick.net/ddm/clk/304595813;131938128;j
_______________________________________________
Blueobelisk-discuss mailing list
Blueobelisk-discuss@lists.sourceforge.net
https://lists.sourceforge.net/lists/listinfo/blueobelisk-discuss

Reply via email to